Back
 ABCR  Vol.5 No.2 , April 2016
Breast Cancer in Western Iraq: Clinicopathological Single Institution Study
Abstract: Background: Breast cancer is the most frequent malignancy of women worldwide; In Iraq, it ranks first among cancers diagnosed in women, but studies on breast cancer among women in Western Iraq are limited. Breast cancer rate in Arabic countries is lower than that in West nations and more common in younger age. The aim of this study is to estimate age of presentation, stage, grade, type and side of tumor and their comparison with other Iraqi regions as well as with some Arabic and West countries. Materials and Methods: This is a descriptive study conducted between 1st of February 2011 to 30th of January 2015 in Western Iraq. 292 cases of breast cancer were enrolled in this study, including 206 cases of mastectomy and 86 cases of lumpectomy. Results: Average age at diagnosis: 47.16 (SD: 12.15), median age at diagnosis: 45 with mode of: 40. Cases with age <50 y: 68.15%. Regarding tumor stages, only 2.39% were presented in pT0 & pT1 categories, and only 2.92% of 206 mastectomy cases were presented in stage 0 & stage I, 12.7% of cases were of grade I. Regarding the types: invasive ductal carcinoma, not otherwise specified type: 88%, medullary type: 6.8%, mucinous type: 2.1% & invasive lobular type: 3.1%. Left side (179)/Right side (113) = 1.58, and the bilaterality was 2.7%. Conclusion: Breast cancer rate among females in Western Iraq is low, but it is relatively higher in younger age group in comparison to other studies and mostly presented beyond early stage with a higher grade.
Cite this paper: Al-Isawi, A. (2016) Breast Cancer in Western Iraq: Clinicopathological Single Institution Study. Advances in Breast Cancer Research, 5, 83-89. doi: 10.4236/abcr.2016.52009.
References

[1]   Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., Straif, K., and International Agency for Research on Cancer Handbook Working Group (2015) Breast-Cancer Screening—Viewpoint of the IARC Working Group. The New England Journal of Medicine, 372, 2353-2358.
http://dx.doi.org/10.1056/NEJMsr1504363

[2]   Simmons, P.S., Jayasinghe, Y.L., Wold, L.E. and Melton III, L.P. (2011) Breast Carcinoma in Young Women. Obstetrics & Gynecology, 118, 529-536.
http://dx.doi.org/10.1097/AOG.0b013e31822a69db

[3]   Assi, H.A., Khoury, K.E., Dbouk, H., Khalil, L.E., Mouhieddine, T.H. and El Saghir, N.S. (2013) Epidemiology and Prognosis of Breast Cancer in Young Women. Journal of Thoracic Disease, 5, S2-S8.

[4]   Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90. Erratum in: CA: A Cancer Journal for Clinicians, 61, 134.
http://dx.doi.org/10.3322/caac.20107

[5]   Najjar, H. and Easson, A. (2010) Age at Diagnosis of Breast Cancer in Arab Nations. International Journal of Surgery, 8, 448-452.

[6]   Tiwari, V., Pande, S.C., Verma, K. and Goel, S. (2015) Is Multiparity a Protective Mechanism in Iraqi Females with Breast Cancer? Need for Detailed Analysis. Clinical Cancer Investigation Journal, 4, 292-293.
http://www.ccij-online.org/text.asp?2015/4/2/292/148933

[7]   Al-Hashimi, M.M. and Wang, X.J. (2014) Breast Cancer in Iraq, Incidence Trends from 2000-2009. Asian Pacific Journal of Cancer Prevention, 15, 281-286.
http://dx.doi.org/10.7314/APJCP.2014.15.1.281

[8]   Majid, R.A., Mohammed, H.A., Hassan, H.A., Abdulmahdi, W.A., Rashid, R.W. and Hughson, M.D. (2012) A Population-Based Study of Kurdish Breast Cancer in Northern Iraq: Hormone Receptor and HER2 Status. A Comparison with ARABIC Women and United States SEER Data. BMC Women’s Health, 12, 16.
http://dx.doi.org/10.1186/1472-6874-12-16

[9]   Alwan, N. (2014) Iraqi Initiative of a Regional Comparative Breast Cancer Research Project in the Middle East. Journal of Cancer Biology & Research, 2, 1016.

[10]   Majid, R.A., Mohammed, H.A., Saeed, H.M., Safar, B.M., Rashid, R.M. and Hughson, M.D. (2009) Breast Cancer in Kurdish Women of Northern Iraq: Incidence, Clinical Stage, and Case Control Analysis of Parity and Family Risk. BMC Women’s Health, 9, 33.
http://dx.doi.org/10.1186/1472-6874-9-33

[11]   WHO (2012) GLOBOCAN 2012: Global Cancer Facts & Figures. 3rd Edition, WHO, Geneva, 41.

[12]   American Joint Committee on Cancer (AJCC) (2010) Breast Cancer Staging, New 7th Edition.

[13]   Mazreku, J., Ziegler, K.L., Scocozza, M. and Brant, M.K. (2014) California Cancer Reporting System Standards, Volume I: Thirteenth Edition 2013, Version 2.3.

[14]   Molah Karim, S.A., Ali Ghalib, H.H., Mohammed, S.A. and Fattah, F.H. (2015) The Incidence, Age at Diagnosis of Breast Cancer in the Iraqi Kurdish Population and Comparison to Some Other Countries of Middle-East and West. International Journal of Surgery, 13, 71-75.
http://dx.doi.org/10.1016/j.ijsu.2014.11.029

[15]   Parikh, D.A., Chudasama, R., Agarwal, A., Rand, A., Qureshi, M.M., Ngo, T. and Hirsch, A.E. (2015) Race/Ethnicity, Primary Language, and Income Are Not Demographic Drivers of Mortality in Breast Cancer Patients at a Diverse Safety Net Academic Medical Center. International Journal of Breast Cancer, 2015, Article ID: 835074.

[16]   Park, I., Kim, J., Kim, M., Bae, S.Y., Lee, S.K., Kil, W.H., Lee, J.E. and Nam, S.J. (2013) Comparison of the Characteristics of Medullary Breast Carcinoma and Invasive Ductal Carcinoma. Journal of Breast Cancer, 16, 417-425.
http://dx.doi.org/10.4048/jbc.2013.16.4.417

[17]   Ha, K.Y., DeLeon, P. and DeLeon, W. (2013) Invasive Mucinous Carcinoma of the Breast. Proceedings (Baylor University. Medical Center), 26, 295-297.

[18]   Dossus, L. and Benusiglio, P.R. (2015) Lobular breast Cancer: Incidence and Genetic and Non-Genetic Risk Factors. Breast Cancer Research, 17, 37.
http://dx.doi.org/10.1186/s13058-015-0546-7

[19]   Singletary, S.E., Patel-Parekh, L. and Bland, K.I. (2005) Treatment Trends in Early-Stage Invasive Lobular Carcinoma. Ann Surg, 242, 281-289.

[20]   Khairy, G.A., Guraya, S.Y., Ahmed, M.E. and Ahmed, M.A. (2005) Bilateral Breast Cancer. Incidence, Diagnosis and Histological Patterns. Saudi Medical Journal, 26, 612-615.

[21]   Gong, S.J., Rha, S.Y., Jeung, H.C., Roh, J.K., Yang, W.I. and Chung, H.C. (2007) Bilateral Breast Cancer: Differential Diagnosis Using Histological and Biological Parameters. Japanese Journal of Clinical Oncology, 37, 487-492.
http://dx.doi.org/10.1093/jjco/hym056

[22]   Nicho, A.M., Yerushalmi, R., Tyldesley, S., Lesperance, M., Bajdik, C.D., Speers, C., Gelmon, K.A. and Olivotto, I.A. (2011) A Case-Match Study Comparing Unilateral With Synchronous Bilateral Breast Cancer Outcomes. Journal of Clinical Oncology (JCO), 29, 4763-4768.
http://dx.doi.org/10.1200/JCO.2011.35.0165

[23]   Zeeneldina, A.A., Ramadanb, M., Elmashadc, N., Fakhrd, I., Diaaa, A. and Mosaada, E. (2013) Breast Cancer Laterality among Egyptian Patients and Its Association with Treatments and Survival. Journal of the Egyptian National Cancer Institute, 25, 199-207.

[24]   Dane, S., Yildirim, S., Koc, M., Aktan, M. and Gundogdu, C. (2008) Asymmetries in Breast Cancer Lateralization and Both Axillary Lymph Node Number and Metastatic Involvement. Lymphology, 41, 75-79.

 
 
Top